{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 451554694
| IUPAC_name = 4-ethylnaphthalen-1-yl-(1-pentylindol-3-yl)methanone
| image = JWH-210_structure.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = Schedule II
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_DE = Anlage II
| legal_status = Illegal in Sweden, I-N(Poland)<ref>{{cite web | title = Ustawa z dnia 15 kwietnia 2011 r. o zmianie ustawy o przeciwdziałaniu narkomanii ( Dz.U. 2011 nr 105 poz. 614 ) | url = http://isap.sejm.gov.pl/DetailsServlet?id=WDU20111050614 | publisher = Internetowy System Aktów Prawnych | accessdate = 12 June 2011}}</ref>
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 824959-81-1
| CAS_supplemental = (JWH-210)<br /> {{CAS|824960-02-3}} (JWH-182)
| ATC_prefix =  
| ATC_suffix =  
| PubChem = 45270396
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 24617616

<!--Chemical data-->
| C=26 | H=27 | N=1 | O=1 
| molecular_weight = 369.498 g/mol
| smiles = c4cccc2c4c(CC)ccc2C(=O)c(c3)c1ccccc1n3CCCCC
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C26H27NO/c1-3-5-10-17-27-18-24(22-13-8-9-14-25(22)27)26(28)23-16-15-19(4-2)20-11-6-7-12-21(20)23/h6-9,11-16,18H,3-5,10,17H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = LACIUQLUNACUKC-UHFFFAOYSA-N
}}

'''JWH-210''' is an [[analgesic]] chemical from the [[naphthoylindole]] family, which acts as a potent [[cannabinoid]] agonist at both the [[Cannabinoid receptor 1|CB<sub>1</sub>]] and [[Cannabinoid receptor 2 (macrophage)|CB<sub>2</sub>]] receptors, with K<sub>i</sub> values of 0.46nM at CB<sub>1</sub> and 0.69nM at CB<sub>2</sub>. It is one of the most potent 4-substituted naphthoyl derivatives in the naphthoylindole series, having a higher [[Dissociation constant#Protein-ligand binding|binding affinity]] (i.e. lower K<sub>i</sub>) at CB<sub>1</sub> than both its 4-methyl and 4-''n''-propyl [[homolog (chemistry)|homologue]]s [[JWH-122]] (CB<sub>1</sub> K<sub>i</sub> 0.69nM) and '''JWH-182''' (CB<sub>1</sub> K<sub>i</sub> 0.65nM) respectively, and than the 4-methoxy compound [[JWH-081]] (CB<sub>1</sub> K<sub>i</sub> 1.2nM).<ref>{{Cite journal |doi= 10.1016/j.bmc.2004.09.050 |pmid= 15582455 |year= 2005 |last= Huffman |first= J.|title= Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists. |volume= 13 |issue= 1 |pages= 89–112 |journal= Bioorganic & Medicinal Chemistry |display-authors=etal}}
</ref> It was discovered by and named after Dr. [[John W. Huffman]].

JWH-210 may be neurotoxic to animals when administered in high doses.<ref>{{cite journal | title=Neurotoxicity of Synthetic Cannabinoids JWH-081 and JWH-210 |author1=Hye Jin Cha |author2=Yeon-Hee Seong |author3=Min-Ji Song |author4=Ho-Sang Jeong |author5=Jisoon Shin |author6=Jaesuk Yun |author7=Kyoungmoon Han |author8=Young-Hoon Kim |author9=Hoil Kang |author10=Hyoung Soo Kim | journal=Biomolecules & Therapeutics | date=November 2015 | volume=23 | issue=6 | pages=597–603 | doi=10.4062/biomolther.2015.057 | pmid=26535086 | pmc=4624077}}</ref>

==Legal Status==

JWH-210 and JWH-122 were banned in Sweden on 1 October 2010 as hazardous goods harmful to health, after being identified as ingredients in "herbal" [[synthetic cannabis]] products.<ref>[http://www.riksdagen.se/webbnav/index.aspx?nid=3911&bet=1999:58 Swedish Code of Statutes Regulation (2010:1086).]</ref><ref>[http://www.lagboken.se/files/SFS/2010/101086.PDF Swedish Code of Statutes Regulation (2010:1086). (pdf)]</ref> The substances JWH-210, JWH-122 and [[JWH-203]] were classified as illegal drugs by the Swedish government as of 1 September 2011.<ref>LVFS 2011:8</ref>

As of October 2015 JWH-210 is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=Chinese | accessdate=1 October 2015}}</ref>

==See also==
*[[JWH-081]]
*[[JWH-193]]
*[[JWH-398]]

==References==
<references/>

{{Cannabinoids}}

[[Category:JWH cannabinoids]]
[[Category:Naphthoylindoles]]
[[Category:Designer drugs]]


{{cannabinoid-stub}}

[[de:JWH-210]]